Hence, upon IL4 engagement, our 4/7ICR delivers a prototypic Th1 cytokine signal (signal 3) that supports cell proliferation, persistence and potent anti-tumor effects, as was confirmed in our primary and rechallenge in vivo tumor models. Here, IL4 is linked to neoplasm.